Skip to main content

Table 1 The association between miR-29a expression and clinicopathological characteristics of included patients

From: miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop

Clinicopathological characteristics

No. of patients

miR-29a expression

P

High

Low

WHO grade

   

 < 0.05

 I

7

6

1

 

 II

7

5

2

 

 III

7

3

4

 

 IV

9

3

6

 

Age

   

0.518

 < 50

14

8

6

 

 ≥ 50

16

9

7

 

Gender

   

0.728

 Male

16

8

8

 

 Female

14

8

6

 

Location

    

 Supratentorial

18

10

8

0.469

 Infratentorial

12

5

7

 

Tumor size

    

 < 3 cm

13

7

5

0.065

 ≥ 3 cm

17

11

6

 
  1. The median expression level of lncRNA- was used as the cutoff